11-Dec-15 India’s Ministry of Health & Family Welfare (MOHFW) and the Central Drugs Standard Control Organization (CDSCO) have met with medical device association representatives to discuss how the country can become a hub for device manufacturing and begin to align with global regulations. The discussion centered on increasing device exports and evaluating new guidance for the industry. [image: RAPS]

08-Dec-15 China's implementation of healthcare reforms, changing the approval process for new medical devices and favoring local manufacturers will restrain growth for US medical manufacturers, says Moody's. China's healthcare reforms will be particularly credit negative for companies that make complex devices, such as Medtronic, Boston Scientific and St Jude. [image: Shannon Stapleton / Reuters]

07-Dec-15 The Chinese medical device market is maturing rapidly, and with it, so is its regulatory presence. Top trends on the horizon for 2016: A move toward localization; research use only loophole closing; imported refurbished products will be a no-no; local bidding for local products; more inspection on the way. [image: MD+DI]

04-Dec-15 In a move aimed to improve the "sustainability of the health insurance system", Chinese political advisors have suggested cutting red tape to encourage domestic development of generic drugs but also establishing tougher standards to assess their quality. [image: Patty Chen / Reuters]

01-Dec-15 When in May-15 Prime Minister Dmitry Medvedev tasked the government with creating a program of pharmaceutical import substitution, foreign companies were worried. Today, 60% of the drugs approved by the Russian government are produced domestically. Under the new policy, this share should increase to 90% by 2018. [image: Getty Images]